Ionis Pharmaceuticals Statistics

Total Valuation

LON:0JDI has a market cap or net worth of GBP 4.92 billion. The enterprise value is 4.79 billion.

Market Cap	4.92B
Enterprise Value	4.79B

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	159.16M
Shares Outstanding	n/a
Shares Change (YoY)	+6.20%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	157.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.86
PB Ratio	13.36
P/TBV Ratio	13.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.50
EV / Sales	9.01
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-11.14

Financial Position

The company has a current ratio of 9.66, with a Debt / Equity ratio of 4.14.

Current Ratio	9.66
Quick Ratio	8.74
Debt / Equity	4.14
Debt / EBITDA	n/a
Debt / FCF	-3.55
Interest Coverage	-5.18

Financial Efficiency

Return on equity (ROE) is -118.62% and return on invested capital (ROIC) is -12.51%.

Return on Equity (ROE)	-118.62%
Return on Assets (ROA)	-10.59%
Return on Invested Capital (ROIC)	-12.51%
Return on Capital Employed (ROCE)	-18.44%
Revenue Per Employee	519,314
Profits Per Employee	-331,630
Employee Count	1,069
Asset Turnover	0.26
Inventory Turnover	43.03

Taxes

Income Tax	-4.74M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.06%
50-Day Moving Average	35.84
200-Day Moving Average	35.05
Relative Strength Index (RSI)	65.98
Average Volume (20 Days)	292

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.33

Income Statement

In the last 12 months, LON:0JDI had revenue of GBP 555.15 million and -354.51 million in losses. Loss per share was -2.32.

Revenue	555.15M
Gross Profit	-140.21M
Operating Income	-365.65M
Pretax Income	-359.26M
Net Income	-354.51M
EBITDA	-356.70M
EBIT	-365.65M
Loss Per Share	-2.32

Full Income Statement

Balance Sheet

The company has 1.66 billion in cash and 1.52 billion in debt, giving a net cash position of 139.07 million.

Cash & Cash Equivalents	1.66B
Total Debt	1.52B
Net Cash	139.07M
Net Cash Per Share	n/a
Equity (Book Value)	368.21M
Book Value Per Share	2.32
Working Capital	1.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -388.38 million and capital expenditures -41.30 million, giving a free cash flow of -429.68 million.

Operating Cash Flow	-388.38M
Capital Expenditures	-41.30M
Free Cash Flow	-429.68M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -25.26%, with operating and profit margins of -65.87% and -63.86%.

Gross Margin	-25.26%
Operating Margin	-65.87%
Pretax Margin	-64.71%
Profit Margin	-63.86%
EBITDA Margin	-64.25%
EBIT Margin	-65.87%
FCF Margin	n/a

Dividends & Yields

LON:0JDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.20%
Shareholder Yield	-6.20%
Earnings Yield	-7.21%
FCF Yield	-8.73%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0JDI has an Altman Z-Score of 0.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	1